SYNAGIS (PALIVIZUMAB) SECURE PLUS+ PROGRAM Trademark Information

Trademark by MedImmune, Inc.

Insurance reimbursement support provided to doctors who administer pharmaceuticals to patients

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (036)
Insurance; financial affairs; monetary affairs; real estate affairs.
First Use Anywhere:: 12/1/1999
First Use In Commerce: 12/1/1999
General Information
Word mark: SYNAGIS (PALIVIZUMAB) SECURE PLUS+ PROGRAM
Status/Status Date:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
1/10/2009
Serial Number: 78053483
Filing Date: 3/16/2001
Registration Number: 2556152
Registration Date: 4/2/2002
Goods and Services: Insurance reimbursement support provided to doctors who administer pharmaceuticals to patients
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 1/8/2002
Last Applicant/Owner:
MedImmune, Inc.
Gaithersburg 20878
Mark Drawing Code: Typeset (Words/letter/Number)
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: ("PROGRAM")
Correspondent:
CARELLA BYRNE BAIN GILFILLAN ET AL
6 BECKER FARM ROAD
ROSELAND NJ 07068
Current Status:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
1/10/2009
Correspondent Search:
WILLIAM SQUIRE is a correspondent of SYNAGIS (PALIVIZUMAB) SECURE PLUS+ PROGRAM trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on